{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:39:54Z","timestamp":1792521594809,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00228-026-04201-9","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:19:50Z","timestamp":1792473590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Levetiracetam versus valproate for new-onset or previously treated but inadequately controlled epilepsy in children: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2337-6588","authenticated-orcid":false,"given":"Abdullah M","family":"Alharran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled M","family":"Alsaleeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed S","family":"Alkhamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batoul A","family":"Taqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"Altaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renad A","family":"Alenezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya F","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqayah H","family":"Dashti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa M","family":"Mugheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem GH","family":"Alshemeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alzain A","family":"Alarki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah ONH","family":"Abdalkareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"4201_CR1","first-page":"CD015287","volume":"2023","author":"N Fleeman","year":"2023","unstructured":"Fleeman N, Panebianco M, Hill RA, Doherty AJ, Nevitt SJ, Boland P et al (2023) Service delivery, behavioural, and self-management interventions for children with epilepsy. Cochrane Database Syst Rev 2023:CD015287","journal-title":"Cochrane Database Syst Rev"},{"key":"4201_CR2","doi-asserted-by":"publisher","first-page":"109360","DOI":"10.1016\/j.yebeh.2023.109360","volume":"146","author":"Y Wu","year":"2023","unstructured":"Wu Y, Zhang R, Tang J, Li X, Wang Y, Li T et al (2023) Multi-dimensional influence of pediatric epilepsy on children and their families: a cross-sectional study. Epilepsy Behav 146:109360","journal-title":"Epilepsy Behav"},{"key":"4201_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S0140-6736(25)00773-1","volume":"406","author":"RN Menon","year":"2025","unstructured":"Menon RN, Cross JH (2025) Childhood epilepsy. Lancet 406:636\u2013649","journal-title":"Lancet"},{"key":"4201_CR4","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1007\/s00415-020-09809-0","volume":"268","author":"M Toledo","year":"2021","unstructured":"Toledo M, Mostacci B, Bosak M, Jedrzejzak J, Thomas RH, Salas-Puig J et al (2021) Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience\u2014a European perspective. J Neurol 268:2735\u20132748","journal-title":"J Neurol"},{"key":"4201_CR5","doi-asserted-by":"publisher","unstructured":"Nevitt SJ, Sudell M, Cividini S, Marson AG, Tudur Smith C (2022) Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev 4(4):CD011412. https:\/\/doi.org\/10.1002\/14651858.CD011412.pub4","DOI":"10.1002\/14651858.CD011412.pub4"},{"key":"4201_CR6","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/S0140-6736(21)00246-4","volume":"397","author":"A Marson","year":"2021","unstructured":"Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G et al (2021) The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 397:1375\u20131386","journal-title":"Lancet"},{"key":"4201_CR7","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/epi.13021","volume":"56","author":"T Tomson","year":"2015","unstructured":"Tomson T, Marson A, Boon P, Canevini MP, Covanis A, Gaily E et al (2015) Valproate in the treatment of epilepsy in girls and women of childbearing potential. Epilepsia 56:1006\u20131019","journal-title":"Epilepsia"},{"key":"4201_CR8","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1212\/01.wnl.0000217916.00225.3a","volume":"66","author":"T Glauser","year":"2006","unstructured":"Glauser T, Ayala R, Elterman R, Mitchell W, Van Orman C, Gauer L et al (2006) Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66:1654\u20131660","journal-title":"Neurology"},{"key":"4201_CR9","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1212\/01.wnl.0000268699.34614.d3","volume":"69","author":"SF Berkovic","year":"2007","unstructured":"Berkovic SF, Knowlton R, Leroy R, Schiemann J, Falter U (2007) Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 69:1751\u20131760","journal-title":"Neurology"},{"key":"4201_CR10","doi-asserted-by":"publisher","first-page":"9861","DOI":"10.1073\/pnas.0308208101","volume":"101","author":"BA Lynch","year":"2004","unstructured":"Lynch BA, Lambeng N, Nocka K, Kensel-Hammes P, Bajjalieh SM, Matagne A et al (2004) The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci 101:9861\u20139866","journal-title":"Proc Natl Acad Sci"},{"key":"4201_CR11","doi-asserted-by":"publisher","unstructured":"Latif Z, Mukhtar M, Rohan A, Shah WF, Aslam Z, Akbar M, Raza HMZ (2025) Comparison of levetiracetam versus sodium valproate as a monotherapy in early childhood epilepsy. Cureus 17(7):e87574. https:\/\/doi.org\/10.7759\/cureus.87574","DOI":"10.7759\/cureus.87574"},{"key":"4201_CR12","first-page":"357","volume":"25","author":"S Bhayana","year":"2021","unstructured":"Bhayana S, Aggarwal A, Narang M, Sharma S, Malhotra R (2021) Comparison of levetiracetam and sodium valproate monotherapy in childhood epilepsy: an open-label randomized trial. Curr Pediatr Res 25:357\u2013361","journal-title":"Curr Pediatr Res"},{"key":"4201_CR13","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"4201_CR14","first-page":"ED000142","volume":"2019","author":"M Cumpston","year":"2019","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JPT et al (2019) Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev 2019:ED000142","journal-title":"Cochrane Database Syst Rev"},{"key":"4201_CR15","first-page":"520","volume":"109","author":"T Gotschall","year":"2021","unstructured":"Gotschall T (2021) EndNote 20 desktop version. J Med Libr Assoc JMLA 109:520","journal-title":"J Med Libr Assoc JMLA"},{"key":"4201_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5:210","journal-title":"Syst Rev"},{"key":"4201_CR17","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"4201_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JP (2021) Risk-of\u2010bias VISualization (robvis): an R package and Shiny web app for visualizing risk\u2010of\u2010bias assessments. Res Synth Methods 12:55\u201361","journal-title":"Res Synth Methods"},{"key":"4201_CR19","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924\u2013926","journal-title":"BMJ"},{"key":"4201_CR20","volume-title":"R: A Language and Environment for Statistical Computing_","author":"R Core Team","year":"2025","unstructured":"R Core Team (2025) R: A Language and Environment for Statistical Computing_. R Foundation for Statistical Computing, Vienna, Austria n.d"},{"key":"4201_CR21","first-page":"5","volume":"1","author":"G Schwarzer","year":"2023","unstructured":"Schwarzer G, Carpenter JR, R\u00fccker G, metasens (2023) Statistical methods for sensitivity analysis in meta-analysis. R Package Version 1:5\u20132","journal-title":"R Package Version"},{"key":"4201_CR22","doi-asserted-by":"publisher","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G (2019) How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health 22(4):153\u2013160. https:\/\/doi.org\/10.1136\/ebmental-2019-300117","DOI":"10.1136\/ebmental-2019-300117"},{"key":"4201_CR23","first-page":"195","volume":"16","author":"L Furuya-Kanamori","year":"2018","unstructured":"Furuya-Kanamori L, Barendregt JJ, Doi SA (2018) A new improved graphical and quantitative method for detecting bias in meta-analysis. JBI Evid Implement 16:195\u2013203","journal-title":"JBI Evid Implement"},{"key":"4201_CR24","doi-asserted-by":"publisher","first-page":"334","DOI":"10.53555\/9f6z4k78","volume":"32","author":"R Devagudi","year":"2025","unstructured":"Devagudi R, Lakshmi GS, Penupothu DG, Devagudi P (2025) A prospective randomized study on raise of liver, enzymes of sodium valproate and levetiracetam in childhood generalized epilepsy in a tertiary care hospital. J Popul Ther Clin Pharmacol 32:334\u2013337. https:\/\/doi.org\/10.53555\/9f6z4k78","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"4201_CR25","doi-asserted-by":"publisher","unstructured":"Mahajan I, Kumar P, Jain A, Bansal U, Singh V, Rathoria E (2025) Sodium valproate versus levetiracetam in pediatric generalized epilepsy: a comparative study. Cureus 17(12):e100114. https:\/\/doi.org\/10.7759\/cureus.100114","DOI":"10.7759\/cureus.100114"},{"key":"4201_CR26","doi-asserted-by":"crossref","unstructured":"Prabhakaran K, Rameshkumar R, Biswal N, Nair PP, Harichandrakumar K (2026) Randomised Controlled Trial on Sodium Valproate and Levetiracetam in Children with New-Onset Epilepsy. Indian J Pediatr 1\u20137","DOI":"10.1007\/s12098-025-05919-7"},{"key":"4201_CR27","unstructured":"Qiang Y, Jiangpeng W, Wenxing Q (2017) Efficacy of valproate on electroencephalography and obesity in children with epilepsy. Biomed Res 0970-938X 28."},{"key":"4201_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2174\/1566524019666190729113321","volume":"19","author":"S Zhou","year":"2019","unstructured":"Zhou S, Zhan Q, Wu X (2019) Effect of levetiracetam on cognitive function and clonic seizure frequency in children with epilepsy. Curr Mol Med 19:699\u2013703","journal-title":"Curr Mol Med"},{"key":"4201_CR29","first-page":"371","volume":"15","author":"R Meena","year":"2025","unstructured":"Meena R, Kaleria T, Mandot S, Rathore R (2025) Levetiracetam Vs Sodium valproate as first-line monotherapy in childhood epilepsy: An open-label randomised controlled trial from western India. Int J Pharm Res Technol IJPRT 15:371\u2013375","journal-title":"Int J Pharm Res Technol IJPRT"},{"key":"4201_CR30","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1111\/j.1467-789X.2010.00800.x","volume":"12","author":"A Verrotti","year":"2011","unstructured":"Verrotti A, D\u2019egidio C, Mohn A, Coppola G, Chiarelli F (2011) Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implications. Obes Rev 12:e32\u201343","journal-title":"Obes Rev"},{"key":"4201_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1210\/jc.2014-3415","volume":"100","author":"CM Apovian","year":"2015","unstructured":"Apovian CM, Aronne LJ, Bessesen DH, McDonnell ME, Murad MH, Pagotto U et al (2015) Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 100:342\u2013362","journal-title":"J Clin Endocrinol Metab"},{"key":"4201_CR32","doi-asserted-by":"publisher","first-page":"e0149686","DOI":"10.1371\/journal.pone.0149686","volume":"11","author":"O Egunsola","year":"2016","unstructured":"Egunsola O, Choonara I, Sammons HM (2016) Safety of levetiracetam in paediatrics: a systematic review. PLoS ONE 11:e0149686","journal-title":"PLoS ONE"},{"key":"4201_CR33","doi-asserted-by":"publisher","first-page":"1783559","DOI":"10.3389\/fneur.2026.1783559","volume":"17","author":"AM Alkhotani","year":"2026","unstructured":"Alkhotani AM (2026) Overview of psychiatric and behavioral adverse effects of levetiracetam. Front Neurol 17:1783559","journal-title":"Front Neurol"},{"key":"4201_CR34","doi-asserted-by":"publisher","first-page":"e213786","DOI":"10.1212\/WNL.0000000000213786","volume":"105","author":"S Hernandez-Diaz","year":"2025","unstructured":"Hernandez-Diaz S, Quinn M, Conant S, Lyons A, Paik H, Ward J et al (2025) Use of antiseizure medications early in pregnancy and the risk of major malformations in the newborn. Neurology 105:e213786","journal-title":"Neurology"},{"key":"4201_CR35","doi-asserted-by":"publisher","first-page":"e209279","DOI":"10.1212\/WNL.0000000000209279","volume":"102","author":"AM Pack","year":"2024","unstructured":"Pack AM, Oskoui M, Williams Roberson S, Donley DK, French J, Gerard EE et al (2024) Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication: practice guideline from the AAN, AES, and SMFM. Neurology 102:e209279","journal-title":"Neurology"},{"key":"4201_CR36","doi-asserted-by":"crossref","unstructured":"Zhang L, Wang C, Li W (2018) A meta-analysis of randomized controlled trials on levetiracetam in the treatment of pediatric patients with epilepsy. Neuropsychiatr Dis Treat 769\u2013779","DOI":"10.2147\/NDT.S151413"},{"key":"4201_CR37","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jamaneurol.2020.0032","volume":"77","author":"BAA Alsfouk","year":"2020","unstructured":"Alsfouk BAA, Brodie MJ, Walters M, Kwan P, Chen Z (2020) Tolerability of antiseizure medications in individuals with newly diagnosed epilepsy. JAMA Neurol 77:574\u2013581","journal-title":"JAMA Neurol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04201-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04201-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04201-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:02:12Z","timestamp":1792519332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04201-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["4201"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04201-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"25 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"272"}}